Search research articles
Contact Us
Filters
Showing results (391-400 of 567) with videos related to
Page
of 57
Sort By:
Immunotherapy
|
November 8, 2023
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study
John M Kirkwood, Lisa A Kottschade, Robert R McWilliams, et al.
Foodborne Pathogens and Disease
|
May 23, 2013
Retrospective analysis of Salmonella, Campylobacter, Escherichia coli, and Enterococcus in animal feed ingredients
Beilei Ge, Patricia C LaFon, Peggy J Carter, et al.
Journal of Food Protection
|
February 22, 2017
Molecular Subtyping and Source Attribution of Campylobacter Isolated from Food Animals
Gregory H Tyson, Heather P Tate, Jason Abbott, et al.
Foodborne Pathogens and Disease
|
July 5, 2012
Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from food animals, retail meat, and humans in the United States 2009
J P Folster, G Pecic, A Singh, et al.
Veterinary Microbiology
|
April 3, 2007
Characterization of multidrug resistant Salmonella recovered from diseased animals
S Zhao, P F McDermott, D G White, et al.
The Journal of Antimicrobial Chemotherapy
|
October 2, 2018
Novel linezolid resistance plasmids in Enterococcus from food animals in the USA
Gregory H Tyson, Jonathan L Sabo, Maria Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma
Jean-François Martini, Elizabeth R Plimack, Toni K Choueiri, et al.
European Urology
|
February 11, 2011
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma
Katherine M Krajewski, Mengye Guo, Annick D Van den Abbeele, et al.
Melanoma Research
|
September 1, 2018
Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients
Sally Y Tan, Julie Najita, Xiaoxue Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2020
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)
Rana R McKay, Bradley A McGregor, Wanling Xie, et al.
Page
of 57
Search research articles
Search
Showing results (391-400 of 567) with videos related to
Sort By:
Page
of 57
Immunotherapy
|
November 8, 2023
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study
John M Kirkwood, Lisa A Kottschade, Robert R McWilliams, et al.
Foodborne Pathogens and Disease
|
May 23, 2013
Retrospective analysis of Salmonella, Campylobacter, Escherichia coli, and Enterococcus in animal feed ingredients
Beilei Ge, Patricia C LaFon, Peggy J Carter, et al.
Journal of Food Protection
|
February 22, 2017
Molecular Subtyping and Source Attribution of Campylobacter Isolated from Food Animals
Gregory H Tyson, Heather P Tate, Jason Abbott, et al.
Foodborne Pathogens and Disease
|
July 5, 2012
Characterization of extended-spectrum cephalosporin-resistant Salmonella enterica serovar Heidelberg isolated from food animals, retail meat, and humans in the United States 2009
J P Folster, G Pecic, A Singh, et al.
Veterinary Microbiology
|
April 3, 2007
Characterization of multidrug resistant Salmonella recovered from diseased animals
S Zhao, P F McDermott, D G White, et al.
The Journal of Antimicrobial Chemotherapy
|
October 2, 2018
Novel linezolid resistance plasmids in Enterococcus from food animals in the USA
Gregory H Tyson, Jonathan L Sabo, Maria Hoffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma
Jean-François Martini, Elizabeth R Plimack, Toni K Choueiri, et al.
European Urology
|
February 11, 2011
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma
Katherine M Krajewski, Mengye Guo, Annick D Van den Abbeele, et al.
Melanoma Research
|
September 1, 2018
Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients
Sally Y Tan, Julie Najita, Xiaoxue Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2020
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)
Rana R McKay, Bradley A McGregor, Wanling Xie, et al.
Page
of 57